Provided by Tiger Trade Technology Pte. Ltd.

Neuraxis, Inc.

7.27
-0.0950-1.29%
Volume:8.64K
Turnover:63.26K
Market Cap:81.28M
PE:-7.65
High:7.38
Open:7.38
Low:7.27
Close:7.36
52wk High:7.97
52wk Low:1.55
Shares:11.19M
Float Shares:7.53M
Volume Ratio:3.31
T/O Rate:0.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9500
EPS(LYR):-0.9500
ROE:-285.36%
ROA:-80.63%
PB:23.94
PE(LYR):-7.65

Loading ...

Company Profile

Company Name:
Neuraxis, Inc.
Exchange:
AMEX
Establishment Date:
2011
Employees:
24
Office Location:
11611 North Meridian St,Suite 330,Carmel,Indiana,United States
Zip Code:
46032
Fax:
- -
Introduction:
NeurAxis, Inc. operates as a neuromodulation therapy device company in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome healthcare companies primarily hospitals and clinics. NeurAxis, Inc. was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is based in Versailles, Indiana.

Directors

Name
Position
Bradley Mitch Watkins
Chairman of the Board and Director
Brian Carrico
President, Chief Executive Officer and Director
Beth Keyser
Independent Director
Gilad Aharon
Independent Director
Kristin Ferge
Independent Director
Christopher Robin Brown
Director

Shareholders

Name
Position
Brian Carrico
President, Chief Executive Officer and Director
Adrian Miranda
Chief Medical Officer, Senior Vice President of Science and Technology
Timothy Henrichs
Chief Financial Officer
Thomas Carrico
Chief Regulatory Officer, Compliance Officer and Privacy Officer